Observation On The Clinical Efficacy Of Acupuncture Combined With Navel Moxibustion In The Treatment Of Chronic Urticaria With Wind-cold Syndrome

Objective:To observe the clinical efficacy of acupuncture combined with Shenque point thunder-fire moxibustion in the treatment of wind-cold chronic urticaria based on navel therapy theory.The clinical efficacy of acupuncture combined with navel moxibustion and cetirizine in the treatment of chronic urticaria of wind-cold type was observed through a clinical randomized controlled trial,and the data before and after the two were compared,in order to provide a safe and no side effect for clinical treatment.Methods:72 patients with cold chronic urticaria who met the research criteria of this topic were randomly divided into treatment group and control group,with 36 patients each.The treatment group adopts acupuncture combined with umbilical moxibustion treatment,acupuncture acupuncture points take Quchi,Waiguan,Blood Sea,Wind Market,Foot Sanli,adjust the depth of the needle according to the patient’s fatness and thinness,twist to get qi after entering the needle,give each acupuncture point an injection every 10 minutes after getting the qi,double-sided wind market,outer guan,quchi,blood sea are administered with twisting diarrhea method,bilateral foot three miles are applied twisting supplementation method,each twisting and diarrhea time is 30 seconds long,the intensity is based on the patient’s tolerance,and the needle is taken after 30 minutes.Acupuncture was applied to the umbilicus with lightning moxibustion for 10 minutes,the above operations were once a day,and after 6 consecutive days of treatment,there was a day of rest for a total of 4 weeks;the control group used oral cetirizine hydrochloride 10 mg 1 hour before bedtime every night for a total of 4 weeks.The urticaria symptom scores,urticaria activity score(Urticaria Activity Score UAS)and the changes in serum total Ig E measurement indicators before treatment and4 weeks after treatment were observed in the two groups,and the clinical efficacy of the two groups was evaluated.Follow-up was conducted 2 weeks after the end of the course of treatment,and the short-term recurrence rate of the two groups was recorded and the shortterm recurrence rate of the two groups was evaluated.All statistical analysis of data is handled using SPSS25.0 software.Results:1.Before treatment,there were no statistically significant differences in Skin lesion integrals(urticaria symptom scores),UAS scores,and Ig E detection indicators between the two groups(P>0.05),which was comparable.2.Skin lesion score(urticaria symptom score): after 2 weeks of treatment,compared with the pre-treatment treatment group,both groups could reduce urticaria symptom score(P<0.05);compared with the treatment group,the treatment group had the same effect as the control group in reducing urticaria symptom score(P>0.05).After 4 weeks of treatment,compared with the pre-treatment group,both groups could reduce the urticaria symptom score(P<0.05),and compared with the inter-group comparison,the treatment group was better than the control group(P<0.05)in reducing the degree of pruritus and the frequency of wheal attacks,and had the same effect as the control group in terms of improving the size and number of wheals,reducing the duration of wheals and the degree of wheythema,and there was no significant difference(P>0.05).3.UAS score: After 2 weeks of treatment,compared with the pre-treatment treatment group,both the therapies could reduce the UAS score,and the difference was statistically significant(P<0.05),and the treatment group was better than the control group in reducing the UAS score between the groups(P<0.05).After 4 weeks of treatment,compared with the pretreatment treatment group,both the treatments could reduce the UAS score,and the difference was statistically significant(P<0.05),and the treatment group was better than the control group in reducing the UAS score between the groups(P<0.05).4.Ig E detection index: compared within the group,both groups could reduce serum Ig E levels(P<0.05);in inter-group comparisons,the treatment group was consistent with the control group(P>0.05).5.Follow-up: After stopping treatment for 2 weeks,the two groups of patients were followed up,and the recurrence rate in the treatment group was 19.23%,and the recurrence rate in the control group was 50.00%.The difference in recurrence rates between the two groups was statistically significant,indicating that acupuncture combined with umbilical moxibustion therapy was superior to oral cetirizine(P<0.05)in reducing the short-term recurrence rate.6.Clinical efficacy:The total effective rate of the treatment group was 91.18%,and the total effective rate of the control group was 85.29%,and the clinical efficacy of the two groups was statistically significant(P<0.05).Conclusions:1.Acupuncture combined with umbilical moxibustion therapy and oral cetirizine in the treatment of cold chronic urticaria can improve the overall symptoms of patients,and the overall efficacy of the two is comparable when the course of treatment reaches 2 weeks,but acupuncture combined with umbilical moxibustion therapy is better than oral cetirizine in reducing the degree of itching and the frequency of wheal attacks after 4 weeks,and the shortterm recurrence rate is low.2.Acupuncture combined with umbilical moxibustion and oral cetirizine in the treatment of wind cold chronic urticaria can significantly reduce the UAS score and reduce the frequency of urticaria,but acupuncture combined with umbilical moxibustion is better than oral cetirizine in reducing the UAS score.3.Both treatments reduce total serum Ig E levels with comparable efficacy.